Deborah Wenkert
Overview
Deborah Wenkert received $2M in total compensation, including $361K in salary, at Inozyme Pharma in 2021.
Source: SEC filing on April 27, 2022.
Related executives
We found seven more executives who work or worked at Inozyme Pharma.
Douglas Treco
Inozyme Pharma
Chief Executive Officer
Axel Bolte
Inozyme Pharma
Chief Executive Officer
Matthew Winton
Inozyme Pharma
Chief Operating Officer
Sanjay Subramanian
Inozyme Pharma
Chief Financial Officer
Henric Bjarke
Inozyme Pharma
Chief Operating Officer
Steven Jungles
Inozyme Pharma
Former Senior Vice President and Chief Technical Operations Officer
Pedro Huertas
Inozyme Pharma